Bipolar Disorder Therapeutics Global Market is Projected to Reach $7.8 Billion by 2030: Market Gains to Continue Amid Rising Prevalence of Bipolar Disorder
15. Juni 2023 06:38 ET
|
Research and Markets
Dublin, June 15, 2023 (GLOBE NEWSWIRE) -- The "Bipolar Disorder Therapeutics: Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for...
Bipolar Disorder Therapeutics Global Market Report 2022: Featuring Key Players AbbVie, Pfizer, GlaxoSmithKline & Others
13. September 2022 07:18 ET
|
Research and Markets
Dublin, Sept. 13, 2022 (GLOBE NEWSWIRE) -- The "Bipolar Disorder Therapeutics Global Market Report 2022" report has been added to ResearchAndMarkets.com's offering.The global bipolar disorder...
Bipolar Disorder Therapeutics Market to Attain Valuation of US$ 6.8 Bn by 2026: Fact.MR Prediction
28. April 2022 09:30 ET
|
FACT.MR
United States, Rockville, MD, April 28, 2022 (GLOBE NEWSWIRE) -- The bipolar disorder therapeutics market is projected to rise at a CAGR of 3.1% from 2022 to 2026, as per this new analysis by...